STAT3 and gastric cancer: To confirm the involvement of STAT3 upregulation in response to cisplatin in human gastric cancer cell lines derived from the metastatic site, the protein level of STAT3 was evaluated in KATO III and SNU-1 cells exposed to 10 μM of cisplatin for 48 and 72 h by western blot analysis (Figure 2A,B).